Showing results (301-310 of 381) with videos related to
Sort By:
Pageof 39
Clinical and Vaccine Immunology : CVI|July 15, 2016
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile InfectionDiane J Schmidt, Gillian Beamer, Jacqueline M Tremblay, et al.Vaccine|May 15, 2003
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activationJoana G Brandão, Rik J Scheper, Sinéad M Lougheed, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 10, 2009
Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3Rieneke van de Ven, Jelle J Lindenberg, Dinja Oosterhoff, et al.Plos One|August 3, 2010
HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approachQiana L Matthews, Aiman Fatima, Yizhe Tang, et al.Molecular Cancer Therapeutics|February 19, 2008
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signalingAdly Yacoub, Pankaj Gupta, Margaret A Park, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
RETRACTED: Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC)Dong Chen, Ayesha Siddiq, Luni Emdad, et al.Gynecologic Oncology|August 7, 2004
Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinomaCharles A Leath, Manjula Kataram, Pradeep Bhagavatula, et al.The Journal of Gene Medicine|September 16, 2004
Evaluation of tissue-specific promoters in carcinomas of the cervix uteriDaniel T Rein, Martina Breidenbach, Dirk M Nettelbeck, et al.Molecular Imaging|September 25, 2014
Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 geneIgor P Dmitriev, Elena A Kashentseva, Kenneth H Kim, et al.International Journal of Oncology|May 24, 2008
Development of an optimized conditionally replicative adenoviral agent for ovarian cancerZeng B Zhu, Baogen Lu, Miey Park, et al.Pageof 39